01A

01A operates under the thesis that experienced operators, specifically those who have scaled companies to significant revenue and market capitalization, are uniquely equipped to guide hyper-growth companies to the next level. They focus on providing operational expertise and guidance to founders navigating the challenges of scaling and go-to-market strategies. Their approach involves actively helping founders learn, adapt, and accelerate their execution pace, transforming innovative products into successful, world-class businesses. They aim to bridge the gap between product-market fit and large-scale company success, offering hands-on support and leveraging the partners' extensive experience in building and scaling some of the world's largest tech companies. 01A focuses on providing the benefit of pattern recognition and rapid execution to their portfolio companies. Their strategy is centered around leveraging their extensive operational experience at companies like Twitter and Facebook to assist founders in scaling their businesses efficiently and effectively. Their hands-on approach involves working closely with founders, identifying areas for improvement, and implementing strategies to drive growth and market leadership. By drawing on their personal experiences in navigating hyper-growth environments, they can offer practical advice and mentorship to help founders avoid common pitfalls and achieve their full potential. The firm specifically invests after product market fit, from series A to C.
0TO9
0TO9 funds, founds, and runs financial businesses across Europe, combining people, capital, and technology to turn untapped opportunities into new European companies. They operate with a builder’s mindset, providing hands-on support to entrepreneurs and growth-stage companies, with a focus on local market understanding and shared experience.
1 Asset Management
Focuses on niche asset classes and value creation through deep specialization in areas like fixed income, private credit (with asset-backed or unsecured loans), veterinary clinics, real estate, and thematic equity aligned with long-term global trends. Emphasizes bold, consistent execution in selected verticals (e.g., airport hotels, student housing, and veterinary clinics).
100A
100A invests in fintech companies and funds across Europe and the US, with a focus on B2B fintech and financial infrastructure.
100IN
Providing €100K to 100 tech startups at the pre-seed stage, focusing on founders and their first check.
1024 Ventures
A venture studio focused on health and wellbeing. It works with founders and service providers through equity partnerships and combines investment with brand, product and operating support.
10D

10D partners with entrepreneurs who transcend spatial and temporal constraints, enabling new markets and capabilities through bold, long-term investments.
10T Holdings

10T Holdings invests in mid-to-late-stage blue-chip companies powering the Digital Asset Ecosystem through primary and secondary opportunities to drive the transition from old to new economies.[1][2][3]
11.2 Capital

11.2 Capital invests in founders solving the biggest challenges facing our world with emerging technologies. They believe great people are leading indicators of a company's success. The firm aims to be one of the most helpful investors to a company and help create something extraordinary. They leverage their technical background, operational experience, and a strong network of advisors and partners to deliver a unique set of resources to entrepreneurs. Their investment strategy is centered around supporting companies across the full range of early-stage company questions. They concentrate on areas where they can provide the most value, including technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings. 11.2 Capital focuses on emerging technologies. This includes a wide range of areas, from fundamental breakthroughs in AI and automation, to transformative applications in space and healthcare. 11.2 capital is particularly interested in founders who are using technology to solve impactful problems at scale.
1105
Antwerp-based venture builder and investor that backs founders and funds. Offers capital, operating experience and hands-on product and technology support.
11VC
Eleven is a venture capital fund that empowers local heroes to build global success. They focus on supporting early-stage technology companies in Europe, specifically Central and Eastern Europe. Their approach involves providing not only capital but also strategic guidance, access to a network of experts and portfolio companies, and operational support to help founders navigate the challenges of building and scaling their businesses. Eleven aims to be a dedicated partner to founders, helping them with networking, introductions, finance, accounting, strategy, and marketing.
13books Capital

13books Capital invests in financial technology companies and partners with fintech founders seeking to scale globally.
14leafs
Focus on technology-driven startups from Pre-Seed to Series A in Life Sciences, Health, Deep Tech, and Digital Tech.
1991 Ventures

Investing in early-stage startups from Central and Eastern Europe (CEE) and Ukraine, focusing on sectors critical to Europe's tech infrastructure and strategic industries.
1Up Ventures

Backing extraordinary people in the ANZ startup space, regardless of industry.
1st Kind by Peugeot Family
The Peugeot family’s investment firm backs founders across Europe in deep technology, industrial applications and climate solutions, from pre-seed through Series A.
201 Ventures

Investor backing early-stage companies advancing freedom and autonomy in Europe.
2050Cap

Based on the provided article, 2050Cap appears to focus on investing in companies addressing interconnected global challenges and opportunities arising from advancements in technology, climate, and health. The firm's investment thesis seems to revolve around supporting innovations that drive positive change in areas like bioengineered foods, autonomous transit, climate adaptation, AI disaster response, fusion energy, and global health equity. They appear to seek companies that not only demonstrate technological prowess but also exhibit a strong commitment to ethical considerations, sustainability, and equitable access to advancements. The article suggests an interest in companies navigating complex regulatory landscapes, forging cross-sector collaborations, and developing adaptive strategies to align technological growth with human and environmental needs. The fund emphasizes the importance of interconnectedness and comprehensive approaches to problem-solving, supporting ventures that consider the collective impact of their innovations on society.
20VC

20VC operates at the intersection of venture capital and media, focusing on AI, infrastructure, and tech-driven innovation. The firm provides insights, analysis, and content to highlight trends in AI, venture capital, and tech industries, emphasizing high-growth markets and disruptive technologies.
2100VC

2100 Ventures invests in the next generation of European founders who are defying the odds to build impactful, long-term businesses. The fund focuses on ambitious, high-growth startups across sectors like technology, consumer, enterprise software, healthcare, fintech, and AI/ML, with a strong emphasis on innovation and scalability.
212 NexT

212 NexT invests in Seed to Series A startups driving disruptive innovations in advanced materials like chemicals, biomaterials, nanomaterials, catalysts, energy efficiency, recycling, and AI-driven discovery.[1]
2150.vc

Backs founders building transformational technologies across energy, industry, materials, and cities, leveraging operational backgrounds to invest where deep technical conviction meets scale, delivering strong returns and measurable real-world outcomes.
21stBio
21st.BIO specializes in delivering precision fermentation technology to accelerate the production of sustainable proteins and peptides. Their platform bridges the gap between lab innovation and industrial-scale manufacturing, leveraging expertise from Novo Nordisk and Novonesis. They offer shared development programs for nature-identical molecules and bespoke projects for exclusive protein assets, enabling faster, lower-risk market entry for partners.
22 Ventures

The provided website content is extremely limited and does not offer any insight into 22 Ventures' investment thesis or strategy. The crawled pages only contain a copyright notice, an image, and a cookie consent request. Therefore, no comprehensive thesis or strategy description can be extracted.